Board-Focused Endocrinology CME Review
Oakstone Intensive Review of Endocrinology and Metabolism 2026 from Cleveland Clinic is a high-yield, case-based online video CME program designed to sharpen your expertise for board preparation and daily clinical practice. Expert faculty ensure you master the latest updates while reinforcing evidence-based best practices across the full spectrum of endocrinology.
In this focused continuing medical education course, you’ll review essential topics including:
- Thyroid & Menopause: Thyroid nodules, thyroid cancer, hyperthyroidism, hypothyroidism, and menopausal management
- Adrenal & Hypertension: Endocrine hypertension, adrenal insufficiency, congenital adrenal hyperplasia (CAH)
- Metabolism & Weight: Hypoglycemia, obesity, and metabolic complications
- Bone & Calcium: Osteoporosis, vitamin D deficiency, hypercalcemia, hypocalcemia
- Pituitary & Gonads: Male and female hypogonadism, pituitary disorders
- Diabetes: Complications, insulin therapy updates, incretin-based therapies
- Special Populations: Pediatric endocrine care, endocrine surgery, transgender health
* Date of Original Release: December 31, 2025
LEARNING OBJECTIVES
At the conclusion of this activity, the participant will be able to:
- Summarize clinical practice issues associated with thyroid nodules and cancer, hyperthyroidism, hypothyroidism, and menopause
- Describe differing management strategies for endocrine hypertension, adrenal insufficiency, congenital adrenal hyperplasia, hypoglycemia, and obesity
- Review case management issues for endocrine surgery and pediatric patients with endocrine disorders
- Describe the potential impact of endocrine disorders in transgender patients
- Summarize diagnostic and management strategies for thyroid, pituitary, and adrenal gland disorders
- Summarize management considerations for metabolic bone disease, osteoporosis, vitamin D deficiency, and hyper/hypocalcemia
- Explain management strategies for male and female hypogonadism
- Describe diabetes complications and the clinical impact of new insulin and incretin therapies
OAKSTONE INTENSIVE REVIEW OF ENDOCRINOLOGY AND METABOLISM 2026








